Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 16, 2021

Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns

Mallinckrodt has received the US Food and Drug Administration (FDA) approval for StrataGraft to treat thermal burns with intact dermal elements in adults.

StrataGraft is made from two types of human skin cells. Credit: Mallinckrodt.